EUVIMEDEUVIMED entdecken
Crossref

Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer

Sahar Valizadeh, Sana Taghiyar, Serajedin Vahidi, Omid Abazari, Mahmood Akhavan Tafti, Javad Zavar Reza

Biochemical Genetics · 2025

DOI: 10.1007/s10528-024-10735-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Genetics, 2025. Verfasst von Sahar Valizadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, School of Medicine, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences & Health Services, Yazd,…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Homeodomain Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer is the most common urinary tract neoplasm, affecting many people annually. Current diagnostic and surveillance methods for bladder cancer are frequently invasive and lack sensitivity and specificity. This study aimed to develop an accurate and non-invasive urine-based gene expression assay, including fibroblast growth factor receptor 3 (FGFR3), homeobox A13 (HOXA13), and polo-like kinase 1 (PLK1), to diagnose non-muscle-invasive bladder cancer (NMIBC) at stages Ta and T1. The samples were acquired from 62 patients with NMIBC, 31 control individuals, and 31 patients with non-cancerous genitourinary tract diseases. The expression levels of three relevant genes were determined using quantitative RT-PCR. In addition, the sensitivity and specificity of the data for these genes were computed. Our results showed that PLK1, HOXA13, and FGFR3 expressions of genes were significantly elevated in patients compared to the control groups (p = 0.0001; p = 0.039). The sensitivity and specificity for the FGFR3 gene were 55% and 76%, respectively (p = 0.39). These parameters for HOXA13 were 100% and 93% (p = 0.0001) and for PLK1 were 100% and 86% (p = 0.0001) for diagnosing and monitoring NMIBC. HOXA13 and PLK 1 exhibited adequate specificity and sensitivity for diagnosis. The results of this research showed that despite the higher expression of these genes in urine, only HOXA13 and PLK1 had sufficient and proper specificity and sensitivity, so the urinary expression of these two genes can be used in future studies for diagnosis and monitoring in cancer bladder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsProtein Serine-Threonine KinasesCell Cycle ProteinsHomeodomain ProteinsProto-Oncogene ProteinsBiomarkers, TumorHumansPolo-Like Kinase 1MaleFemaleMiddle AgedAgedReceptor, Fibroblast Growth Factor, Type 3Gene Expression Regulation, NeoplasticAdultNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

FGFR3HOXA13Non-muscle invasive bladder cancer (NMIBC)PLK1

Substanzen

Protein Serine-Threonine KinasesPolo-Like Kinase 1Cell Cycle ProteinsHomeodomain ProteinsProto-Oncogene Proteinshomeobox protein HOXA13Biomarkers, TumorReceptor, Fibroblast Growth Factor, Type 3FGFR3 protein, human

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, School of Medicine, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences & Health Services, Yazd, Iran.
  • Department of Clinical Biochemistry, International Campus, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Department of Pathology, School of Medicine, Shahid Sadoughi University of Medical Sciences & Health Services, Yazd, Iran.
  • Department of Clinical Biochemistry, School of Medicine, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences & Health Services, Yazd, Iran. jzavar@ssu.ac.ir.

Zitieren

APA

Valizadeh, S., Taghiyar, S., Vahidi, S., Abazari, O., Akhavan Tafti, M., & Zavar Reza, J. (2025). Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer. Biochemical Genetics. https://doi.org/10.1007/s10528-024-10735-3

Vancouver

Valizadeh S, Taghiyar S, Vahidi S, Abazari O, Akhavan Tafti M, Zavar Reza J. Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer. Biochemical Genetics. 2025. doi:10.1007/s10528-024-10735-3

BibTeX
@article{Valizadeh2025,
  author = {Valizadeh, Sahar and Taghiyar, Sana and Vahidi, Serajedin and Abazari, Omid and Akhavan Tafti, Mahmood and Zavar Reza, Javad},
  title = {Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer},
  journal = {Biochemical Genetics},
  year = {2025},
  doi = {10.1007/s10528-024-10735-3}
}
Kostenlos starten →